Phathom Pharmaceuticals, Inc. PHAT Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 87.1%+1.5pp | 85.6%+10.1pp | 75.5%— | —— | |
| Operating margin | -91.4%+411pp | -502.2%+24,030pp | -24,532.6%— | —— | |
| Net margin | -126.3%+479pp | -605.1%+28,954pp | -29,558.9%— | —— | |
| EBITDA margin | -91%+410pp | -500.7%+23,947pp | -24,448.2%— | —— | |
| Free cash flow margin | -95.4%+388pp | -483.1%+19,930pp | -20,412.6%— | —— | |
| Returns | |||||
| Return on assets | -69.4%+15.0pp | -84.4%-14.7pp | -69.7%+42.0pp | -111.6%-52.2pp | |
| Efficiency | |||||
| Asset turnover | 0.5×+0.4× | 0.1×+0.1× | 0×— | 0×— | |
| Inventory turnover | 1.4×+0.6× | 0.8×— | —— | —— | |
| Liquidity | |||||
| Current ratio | 1.7×-2.5× | 4.2×-6.0× | 10.2×+4.1× | 6.1×-3.7× | |
| Quick ratio | 1.6×-2.5× | 4.1×-6.0× | 10×+3.9× | 6.1×-3.7× | |
| Cash ratio | 1×-2.5× | 3.5×-6.4× | 9.8×+3.9× | 5.9×-3.8× | |
| Leverage | |||||
| Debt-to-assets | 0.8×+0.3× | 0.5×+0.2× | 0.3×-0.3× | 0.6×+0.1× | |
| Interest coverage | -2.3×+1.5× | -3.9×+0.1× | -4×+2.3× | -6.3×+13.6× | |
| Per Share | |||||
| Book value per share | -$6.01-49.7% | -$4.01-183% | -$1.42+25.8% | -$1.91-198% | |
| Valuation | |||||
| Market capitalization | $846.21M+13.4% | $555.22M+6.1% | $523.1M+12.0% | $466.99M-25.0% | |
| Enterprise value | $831.61M+12.7% | $459.87M+63.8% | $280.73M-31.3% | $408.67M-23.0% | |
| Price / sales | 4.1×-5.0× | 10×-757× | 767×— | —— | |
| EV / sales | 4×-4.8× | 8.3×-403× | 411.6×— | —— | |
| Free cash flow yield | -11.9%+27.0pp | -48.1%-21.5pp | -26.6%+5.0pp | -31.6%-7.7pp | |
| Earnings yield | -19.1%+28.5pp | -60.2%-21.7pp | -38.5%+3.8pp | -42.3%-19.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Phathom Pharmaceuticals, Inc.'s profit margins?
- Phathom Pharmaceuticals, Inc. (PHAT) runs a 84.9% gross margin and a -47.1% operating margin, with a -76.8% net margin.
- Where do Phathom Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Phathom Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
